AUVELITY

Dextromethorphan hydrobromide, bupropion hydrochloride · Axsome Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AUVELITY, covering 2022-08-18 to 2025-11-05. Get the full timeline:

Most recent: FDA Approved: AUVELITY — Supplemental Application (Axsome Therapeutics, Inc.)